151 related articles for article (PubMed ID: 31655048)
21. Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).
Sahin-Calapoglu N; Tan M; Soyoz M; Calapoglu M; Ozcelik N
Neuromolecular Med; 2009; 11(2):106-13. PubMed ID: 19381883
[TBL] [Abstract][Full Text] [Related]
22. Charcot-Marie-Tooth-related gene GDAP1 complements cell cycle delay at G2/M phase in Saccharomyces cerevisiae fis1 gene-defective cells.
Estela A; Pla-Martín D; Sánchez-Piris M; Sesaki H; Palau F
J Biol Chem; 2011 Oct; 286(42):36777-86. PubMed ID: 21890626
[TBL] [Abstract][Full Text] [Related]
23. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria.
Pedrola L; Espert A; Wu X; Claramunt R; Shy ME; Palau F
Hum Mol Genet; 2005 Apr; 14(8):1087-94. PubMed ID: 15772096
[TBL] [Abstract][Full Text] [Related]
24. Two recessive intermediate Charcot-Marie-Tooth patients with GDAP1 mutations.
Chung KW; Hyun YS; Lee HJ; Jung HK; Koo H; Yoo JH; Kim SB; Park CI; Kim HN; Choi BO
J Peripher Nerv Syst; 2011 Jun; 16(2):143-6. PubMed ID: 21692914
[TBL] [Abstract][Full Text] [Related]
25. Early onset Charcot-Marie-Tooth disease caused by a homozygous Leu239Phe mutation in the GDAP1 gene.
Kabzinska D; Drac H; Rowinska-Marcinska K; Fidzianska A; Kochanski A; Hausmanowa-Petrusewicz I
Acta Myol; 2006 Jun; 25(1):34-7. PubMed ID: 17039978
[TBL] [Abstract][Full Text] [Related]
26. Structural and functional divergence of GDAP1 from the glutathione S-transferase superfamily.
Googins MR; Woghiren-Afegbua AO; Calderon M; St Croix CM; Kiselyov KI; VanDemark AP
FASEB J; 2020 May; 34(5):7192-7207. PubMed ID: 32274853
[TBL] [Abstract][Full Text] [Related]
27. Neuroinflammation in the pathogenesis of axonal Charcot-Marie-Tooth disease caused by lack of GDAP1.
Fernandez-Lizarbe S; Civera-Tregón A; Cantarero L; Herrer I; Juarez P; Hoenicka J; Palau F
Exp Neurol; 2019 Oct; 320():113004. PubMed ID: 31271761
[TBL] [Abstract][Full Text] [Related]
28. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
[TBL] [Abstract][Full Text] [Related]
29. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.
Bouhouche A; Birouk N; Azzedine H; Benomar A; Durosier G; Ente D; Muriel MP; Ruberg M; Slassi I; Yahyaoui M; Dubourg O; Ouazzani R; LeGuern E
Brain; 2007 Apr; 130(Pt 4):1062-75. PubMed ID: 17347251
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease.
Ammar N; Nelis E; Merlini L; Barisić N; Amouri R; Ceuterick C; Martin JJ; Timmerman V; Hentati F; De Jonghe P
Neuromuscul Disord; 2003 Nov; 13(9):720-8. PubMed ID: 14561495
[TBL] [Abstract][Full Text] [Related]
31. Autosomal recessive axonal form of Charcot-Marie-Tooth Disease caused by compound heterozygous 3'-splice site and Ser130Cys mutation in the GDAP1 gene.
Kabzińska D; Kochański A; Drac H; Ryniewicz B; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
Neuropediatrics; 2005 Jun; 36(3):206-9. PubMed ID: 15944907
[TBL] [Abstract][Full Text] [Related]
32. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
33. Identification and functional characterization of novel GDAP1 variants in Chinese patients with Charcot-Marie-Tooth disease.
Chen CX; Li JQ; Dong HL; Liu GL; Bai G; Wu ZY
Ann Clin Transl Neurol; 2020 Dec; 7(12):2381-2392. PubMed ID: 33136338
[TBL] [Abstract][Full Text] [Related]
34. Brain involvement in Charcot-Marie-Tooth disease due to ganglioside-induced differentiation associated-protein 1 mutation.
Al-Ghamdi F; Anselm I; Yang E; Ghosh PS
Neuromuscul Disord; 2017 Sep; 27(9):848-851. PubMed ID: 28673555
[TBL] [Abstract][Full Text] [Related]
35. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
36. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
Cartoni R; Martinou JC
Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
[TBL] [Abstract][Full Text] [Related]
37. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
[TBL] [Abstract][Full Text] [Related]
38. Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes.
Marco A; Cuesta A; Pedrola L; Palau F; Marín I
Mol Biol Evol; 2004 Jan; 21(1):176-87. PubMed ID: 14595091
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria and calcium defects correlate with axonal dysfunction in GDAP1-related Charcot-Marie-Tooth mouse model.
Civera-Tregón A; Domínguez L; Martínez-Valero P; Serrano C; Vallmitjana A; Benítez R; Hoenicka J; Satrústegui J; Palau F
Neurobiol Dis; 2021 May; 152():105300. PubMed ID: 33582224
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy.
Senderek J; Bergmann C; Ramaekers VT; Nelis E; Bernert G; Makowski A; Züchner S; De Jonghe P; Rudnik-Schöneborn S; Zerres K; Schröder JM
Brain; 2003 Mar; 126(Pt 3):642-9. PubMed ID: 12566285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
